Department of Cardiology, The Second Hospital of Hebei Medical University, Shijiazhuang, China.
Department of Cardiology, The First Hospital of Hebei Medical University, Shijiazhuang, China.
Br J Hosp Med (Lond). 2022 May 2;83(5):1-16. doi: 10.12968/hmed.2021.0594. Epub 2022 May 6.
Heart failure has many causes. Although new drugs, devices and technologies are available, the survival rate and prognosis of patients with heart failure remain poor, placing a significant burden on individuals and society. Attempts to improve outcomes for patients with heart failure include developing prognostic risk scores. With medical advances, however, previous heart failure risk scores are not fully applicable to current practice, particularly because of the classification as heart failure with reduced ejection fraction, heart failure with mildly reduced ejection fraction, and heart failure with preserved ejection fraction. This article describes the use of risk prediction scores for heart failure patients with different clinical status and discusses their clinical applicability.
心力衰竭有多种病因。尽管有新的药物、设备和技术可用，但心力衰竭患者的生存率和预后仍然较差，给个人和社会带来了巨大负担。为改善心力衰竭患者的预后，人们尝试开发预后风险评分。然而，随着医学的进步，以前的心力衰竭风险评分并不完全适用于当前的实践，特别是因为心力衰竭的射血分数降低、射血分数轻度降低和射血分数保留的分类。本文描述了不同临床状态的心力衰竭患者使用风险预测评分的情况，并讨论了其临床适用性。
